CTRI Number |
CTRI/2019/10/021791 [Registered on: 24/10/2019] Trial Registered Prospectively |
Last Modified On: |
20/08/2020 |
Post Graduate Thesis |
Yes |
Type of Trial |
Interventional |
Type of Study
|
Drug |
Study Design |
Randomized, Parallel Group Trial |
Public Title of Study
|
To determine the ideal maintenance fluid for critically ill children. |
Scientific Title of Study
|
COMPARISON OF 0.45% AND 0.9%
SALINE IN 5% DEXTROSE AS
MAINTENANCE FLUIDS IN CHILDREN
ADMITTED WITH ACUTE ILLNESS. |
Trial Acronym |
|
Secondary IDs if Any
|
Secondary ID |
Identifier |
NIL |
NIL |
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
Name |
Kumar Ratnjeet |
Designation |
Post Graduate Student |
Affiliation |
Maulana Azad Medical College and associated Lok Nayak Hospitals. |
Address |
301, Second floor,Type 2 quarters, Mirdard Lane Maulana Azad Medical College and associated Lok Nayak Hospitals, Bahadur Shah Zafar Marg, Delhi - 110002 Central DELHI 110002 India |
Phone |
07838695570 |
Fax |
|
Email |
krat240@gmail.com |
|
Details of Contact Person Scientific Query
|
Name |
Dr U Jhamb |
Designation |
Director Professor and HoD of Pediatrics |
Affiliation |
Maulana Azad Medical College and associated Lok Nayak Hospitals. |
Address |
Department of Pediatrics, Maulana Azad Medical College and Lok Nayak Hospitals, 110002 Maulana Azad Medical College and associated Lok Nayak Hospitals, Bahadur Shah Zafar Marg, Delhi - 110002 Central DELHI 110002 India |
Phone |
9968604309 |
Fax |
|
Email |
ujhamb@hotmail.com |
|
Details of Contact Person Public Query
|
Name |
Dr U Jhamb |
Designation |
Director Professor and HoD of Pediatrics |
Affiliation |
Maulana Azad Medical College and associated Lok Nayak Hospitals. |
Address |
Department of Pediatrics, Maulana Azad Medical College and associated Lok Nayak Hospitals, Delhi 110002 Maulana Azad Medical College and associated Lok Nayak Hospitals, Bahadur Shah Zafar Marg, Delhi - 110002 Central DELHI 110002 India |
Phone |
9968604309 |
Fax |
|
Email |
ujhamb@hotmail.com |
|
Source of Monetary or Material Support
|
|
Primary Sponsor
|
Name |
Department of Pediatrics |
Address |
Maulana Azad Medical College |
Type of Sponsor |
Government medical college |
|
Details of Secondary Sponsor
|
|
Countries of Recruitment
|
India |
Sites of Study
|
No of Sites = 1 |
Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
Kumar Ratnjeet |
Lok Nayak Hospitals |
Department of Pediatrics, Lok Nayak and associated hospitals, Maulana Azad Medical College, Bahadur Shah Zafar Marg, Delhi-110002 Central DELHI |
07838695570
krat240@gmail.com |
|
Details of Ethics Committee
|
No of Ethics Committees= 1 |
Name of Committee |
Approval Status |
Institutional ethics committee |
Approved |
|
Regulatory Clearance Status from DCGI
|
|
Health Condition / Problems Studied
|
Health Type |
Condition |
Patients |
(1) ICD-10 Condition: R790||Abnormal level of blood mineral, |
|
Intervention / Comparator Agent
|
Type |
Name |
Details |
Intervention |
Intravenous Fluid adminstration in critically ill Pediatric Patients |
After chosing the patients according to exclusion criteria , two groups will be randomly selected. With a sealed envelope member of each group will be chosen. After that according to the group each one will be started with either 0.45% Normal Saline in 5% Dextrose or 0.9% Normal Saline in 5% Dextrose according to Holliday-Segars formula for a maximum duration of 3 days and then both the groups will be compared. |
Comparator Agent |
nil |
nil |
|
Inclusion Criteria
|
Age From |
3.00 Month(s) |
Age To |
12.00 Year(s) |
Gender |
Both |
Details |
All the children more than 3 months and less than 12 years of age requiring fluid management.
|
|
ExclusionCriteria |
Details |
a) Children with age less than 3 months of age and more than 12 years of age.
b ) Children who have received more than 72 hours of intravenous fluid.
c) Children who are receiving drugs affecting sodium levels , i.e. Diuretics etc.
d) Children with Renal Disease ( AKI), Cardiac disease ( CHF) or Pituitary dysfunction , Diabetes mellitus.
e) Children with baseline sodium values, < 130 meq/dl and > 145 meq/dl.
|
|
Method of Generating Random Sequence
|
Computer generated randomization |
Method of Concealment
|
Sequentially numbered, sealed, opaque envelopes |
Blinding/Masking
|
Participant and Investigator Blinded |
Primary Outcome
|
Outcome |
TimePoints |
Proportion of subjects developing hyponatremia after receiving designated fluid for the specified time.
|
72 hours |
|
Secondary Outcome
|
Outcome |
TimePoints |
1. Change in serum sodium levels from the baseline at 48,72 hours in whom iv fluids are continued.
2. Occurence of hyponatremia and hypernatremia. |
72 hours |
|
Target Sample Size
|
Total Sample Size="162" Sample Size from India="162"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
Phase of Trial
|
N/A |
Date of First Enrollment (India)
|
23/11/2019 |
Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
Date of First Enrollment (Global) |
Date Missing |
Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
Estimated Duration of Trial
|
Years="0" Months="10" Days="0" |
Recruitment Status of Trial (Global)
Modification(s)
|
Not Applicable |
Recruitment Status of Trial (India) |
Closed to Recruitment of Participants |
Publication Details
Modification(s)
|
Not yet applicable |
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
Brief Summary
Modification(s)
|
Hospital acquired acute Hyponatremia is increasingly recognised as the cause of morbidity and mortality in children. It has been attributed primarily to the use of hypotonic intravenous fluids to maintain fluid an electrolyte balance. The use of isotonic fluid (0.9% Normal Saline with 5% Dextrose) is recommended in most circumstances. Hypotonic intravenous fluids containing less than or equal to 0.45% NaCL shouldn’t be used to provide as a routine iv fluid maintenance requirement. |